News & Media

NasoNeb®, a Monaghan Medical Corporation brand is a global developer and manufacturer of intranasal drug delivery systems inspired by ENT clinics and designed with healthcare specialists in mind.

Jun 16, 2022

NasoNeb®

NasoNeb is now a Division of Monaghan Medical Corporation

NasoNeb®, Inc. is proud to announce their integration with Monaghan Medical Corporation (“Monaghan Medical”) in Plattsburgh, New York. Monaghan Medical is a leader in the development, manufacture, and distribution of medical devices that improve quality of life of patients with lower respiratory diseases, such as asthma, Cystic Fibrosis, and COPD. 

Oct 28, 2021

NasoNeb®

NasoNeb Welcomes Leading Otolaryngologists to Medical Advisory Board

NasoNeb, Inc. (the “Company” or “NasoNeb”), a developer of innovative intranasal drug delivery and nasal care solutions, is proud to welcome Dr. Brian Rotenberg and Dr. Rodney Schlosser to the Company’s newly-formed Medical Advisory Board.

May 1, 2019

DRUG STORE NEWS

NasoNeb finds distinct way to deliver sinus relief

Officials at NasoNeb felt that consumers were being offered inadequate nasal therapy delivery systems, so they developed a product that they believe stands above the crowd. Bill Flickinger, the company’s president, said that NasoNeb has a solid alternative in a conversation with Drug Store News.

Mar 14, 2017

GLOBE NEWSWIRE

MedInvent Receives CE Mark for NasoNeb II Nasal Nebulizer

Medical Device Company Receives ISO and CMDCAS Certification; Signs First European Distributor

MedInvent, LLC, is pleased to announce CE Marking of its patented intranasal delivery device, the NasoNeb II Nasal Nebulizer, manufactured, marketed and sold in the United States since 2009. MedInvent is also pleased to announce its first EU distribution contract with Vedise Hospital in Rome, to market the NasoNeb System in Italy, San Marino and Vatican City. Vedise Hospital has marketed ENT products for over 20 years, serving Otolaryngologists in Italy. 

Mar 14, 2017

MED GADGET

NasoNeb II Nasal Nebulizer Gets Green Light in Europe

MedInvent, a company based in Medina, Ohio, received European CE Mark approval for its NasoNeb II Nasal Nebulizer. The device is intended for patients with chronic sinusitis and allergic rhinitis, delivering drugs (typically budesonide) into the nasal and paranasal sinus cavities.